Product name:
NY-ESO-1(157-167)Sequence:
SLLMWITQCFL
Purity: 95% by
HPLC
Counter
ion: Trifluoacetate
Format: Lyophilized
powder
Description: The NY-ESO-1 antigen is a
classic CT antigen initially identified by SEREX (serological analysis of
recombinant cDNA expression) analysis of an esophageal cancer patient and then
found to be expressed in a variable proportion of a wide range of different
tumor types, including melanoma, breast, ovary, and lung cancers. The
cancer-testis antigen NY-ESO-1 is one of the most promising candidates for
generic vaccination of cancer patients.
Uniprot
ID: P78358
Usage: For
Scientific Research Use Only, Not for Human Use.
Reference:
Vaccine, Volume
32, Issue 8, 12
February 2014, Pages
957-964
Cancer
Immunol Res January 2014 2; 37.
J Clin
Invest. 2002;110(12):1813–1822.